ReviewDiabetologia2025
Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers.
Jillian Collins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewDiabetologia2025
Jillian Collins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.